|
Monday, February 28 — 8:00 AM — CC BRA
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section A - Genitourinary Pathology
Chaired by: John Eble and Samson Fine
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Evaluation of a Novel ERG Antibody in Prostate Cancer and Correlation with TMPRSS2-ERG Gene Rearrangement Status by FISH, ACGH and ERG mRNA Expression.
(818)
A Gopalan, M Dudas, MA Leversha, BS Taylor, N Schultz, H Hieronymous, Y Chen, H Al-Ahmadie, SW Fine, SK Tickoo, CL Sawyers, WL Gerald, VE Reuter - MSKCC, New York
|  Add |
| 8:15 |
The Utility of Novel Immunohistochemical Marker ERG in Detecting Prostate Cancer Following Atypical Prostate Biopsies: Will New Tumor Markers Be of Value in Such Circumstance?
(826)
H He, C Magi-Galluzzi, P Carver, S Falzarano, K Smith, M Rubin, M Zhou - Cleveland Clinic; Weill Cornell Medical College, New York; Peking University, Health Science Center, Beijing, China
| Add |
| 8:30 |
Towards the Development of a Multiplex Prostate Cancer Specific Biomarker.
(912)
K Park, S Banerjee, F Demichelis, MA Rubin - Weill Cornell Medical College, New York
| Add |
| 8:45 |
Prognostic Relevance of the Revised pN Stages in the 7th TNM Classification for Bladder Cancer.
(811)
A Fleischmann, GN Thalmann, R Seiler - University of Bern, Switzerland; , Bern, Switzerland
| Add |
| 9:00 |
Lymphovascular Invasion Is a Risk Factor for Understaging in pT1 Urothelial Carcinoma of the Bladder.
(760)
M Braun, G Gakis, T Todenhofer, F Fend, A Stenzl, S Perner - University Hospital Bonn, Germany; University Hospital Tuebingen, Germany
| Add |
| 9:15 |
Urachal Carcinoma: A Clinicopathologic Study of 46 Cases.
(790)
J Dhillon, B Czerniak, CC Guo - University of Texas M.D. Anderson Cancer Center, Houston
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Validation of AJCC 2009 Tumor Staging of 681 N0M0 Clear Cell Renal Cell Carcinoma Treated by Radical Nephrectomy.
(817)
JM Gonzalez-Berjon, LD Truong, JY Ro, AG Ayala, SS Shen - The Methodist Hospital and Weill Medical College of Cornell University, Houston, TX
| Add |
| 11:15 |
Refining the Histologic Criteria of Perinephric and Renal Sinus Fat Invasion for Staging Clear Cell Renal Cell Carcinoma.
(750)
H Aydin, P Elson, B Rini, R Baehner, C Magi-galluzzi, M Zhou - Cleveland Clinic; Genomic Health, redwood
| Add |
| 11:30 |
4-miRNA Signature To Predict Clear Cell Renal Cell Carcinoma Metastasis and Prognosis.
(976)
H Wu, X Wu, L Weng, X Li, C Guo, SK Pal, JM Jin, RA Nelson, B Mu, SH Onami, JJ Wu, NH Ruel, H Gao, M Covarrubias, RA Figlin, LM Weiss - City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
| Add |
| 11:45 |
Alternative Pathways of Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas.
(953)
E Stankiewicz, D Mesher, M Ng, J Cuzick, D Prowse, F Hiscock, Y-J Lu, W Lam, N Watkin, C Corbishley, DM Berney - Barts and The London School of Medicine, Queen Mary, University of London, United Kingdom; St George's Hospital, London, United Kingdom
| Add |
|
|
